Spatial Transcriptomics How It Works and Why It Matters

Spatial Transcriptomics: How It Works and Why It Matters

Table of Contents

Spatial transcriptomics measures gene expression while preserving the spatial architecture of the tissue. Unlike scRNA-seq — which loses location information when you dissociate the tissue — spatial methods tell you not just which genes are expressed, but where.

Why spatial information matters

Tissue function depends on spatial organization: which cells touch which, how far signaling molecules travel, how immune cells infiltrate tumors, how stem cell niches are organized. A tumor with the same scRNA-seq profile can have wildly different prognoses depending on whether immune cells are excluded, surrounding the tumor, or infiltrated. Spatial context is biology you can’t recover from dissociated single-cell data.

The two technological approaches

Sequencing-based

Tissue is placed on a slide with spatially barcoded capture spots. mRNA from each spot is captured, the spatial barcode tags it, and the result is sequenced. Each spot’s transcriptome is positioned in 2D coordinates.

Examples: 10x Genomics Visium (55 µm spots, ~1–10 cells per spot), Visium HD (2 µm bins, near single-cell), Stereo-seq (sub-cellular resolution).

Imaging-based (in situ)

Targeted gene panels are detected directly in tissue using fluorescent probes, with multiple rounds of imaging encoding gene identity. Subcellular resolution and multiplex imaging in the same section.

Examples: 10x Xenium, NanoString CosMx, Vizgen MERSCOPE/MERFISH.

Comparison

FeatureVisiumXenium / CosMx / MERFISH
Resolution~55 µm spots (HD: 2 µm bins)Subcellular
Genes profiledWhole transcriptomeTargeted panels (100–5,000 genes)
ThroughputLower (per slide)Higher (single section)
Cost per sampleHigherVariable
Sample typeFresh frozen + FFPEFFPE-friendly

Standard workflow

  1. Sample preparation — fresh frozen tissue sections or FFPE
  2. Tissue placement on slide
  3. Permeabilization and capture (sequencing-based) or hybridization (imaging-based)
  4. Library prep and sequencing, or imaging cycles
  5. Computational alignment of expression to histology image
  6. Analysis: clustering, deconvolution, neighborhood analysis

Analysis approaches

  • Spot-level clustering: Identify spatial domains corresponding to different tissue regions
  • Cell-type deconvolution: For sequencing-based methods, infer cell types per spot using paired scRNA-seq references (Cell2location, RCTD, SPOTlight)
  • Spatially variable gene detection: Genes whose expression depends on location (SpatialDE, SPARK)
  • Cell-cell interaction inference: Use neighbor relationships to identify likely paracrine signaling

Common applications

  • Tumor microenvironment mapping
  • Brain atlases (regional gene expression patterns)
  • Developmental biology (spatial gradients during organogenesis)
  • Inflammation studies (immune infiltrate organization)
  • Drug response in tissue context

Common pitfalls

  • Tissue quality matters enormously. RNA integrity drops fast in fresh-frozen tissue handling and in old FFPE blocks
  • Sample alignment errors — image registration to expression data must be checked carefully
  • Resolution mismatch — Visium spots contain multiple cells; deconvolution is required for cell-type inference
  • Targeted panels miss biology — imaging-based methods only detect what’s on the panel

The future

Subcellular-resolution sequencing (Stereo-seq, Visium HD) and large-panel imaging (1000+ genes) are converging. Pair this with spatial proteomics (CODEX, IMC), and you can describe tissue architecture in extraordinary detail.

Spatial transcriptomics complements scRNA-seq, doesn’t replace it. Use scRNA-seq for cell-type granularity and dynamics; use spatial for architecture and tissue-level context. Many of the strongest current studies pair the two.

Featured Articles

The Iran War Is Now Hitting Pharma Supply Chains Directly
Daily Updates

The Iran War Is Now Hitting Pharma Supply Chains Directly

The Iran war’s impact on pharmaceutical supply chains is no longer theoretical. Evonik, a major supplier of pharma-grade amino and keto acids, announced a 15% price increase effective immediately, citing rising energy, raw material, and shipping costs caused by the conflict. This is the first

Read More »
Makary Is Out. The FDA Has No Permanent Commissioner.
Daily Updates

Makary Is Out. The FDA Has No Permanent Commissioner.

It’s over. FDA Commissioner Marty Makary resigned on Tuesday after 13 months in the role. The resignation followed days of reporting that the White House had signed off on a plan to replace him. The final trigger was a disagreement over flavored e-cigarette authorization, which

Read More »

Join 85,000+ Biotech, MedTech, and Pharma Leaders

Your Daily Edge in Biotech, MedTech, and Pharma

Get trusted, high-signal updates every morning
Breakthroughs, trial data, deals, and the news that matters